Skip to main content

DarioHealth Corp (DRIO)

Health Services Health Care
Stock AI

Financial Metrics

Price to Earnings-2.05x
Revenue Growth (1Y)-22.65%
Debt to Equity0.57x

Strengths

Stock Chart

Valuation

DarioHealth Corp is overvalued

News

All
Press Releases
News
Filings
 DarioHealth Reports Second Quarter 2026 Financial Results
August 11, 2026 DarioHealth Reports Second Quarter 2026 Financial Results
10-Q Quarterly Report for 2026 Q2
August 11, 202610-Q Quarterly Report for 2026 Q2
 Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand
August 04, 2026 Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand
 DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026
August 03, 2026 DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026
 Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience
July 30, 2026 Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience
 Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
July 22, 2026 Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
 Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform
July 16, 2026 Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform
 Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%
July 13, 2026 Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%
 Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
July 06, 2026 Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
 Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy
July 02, 2026 Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy
 Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships
June 30, 2026 Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships
 Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale
June 29, 2026 Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale
 Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform
June 08, 2026 Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform
 Dario More Than Doubles Addressable Market in Solera Health's Network via Expanded Hypertension Program, With Dario Now Reaching Greater Than 500,000 Eligible Lives
May 26, 2026 Dario More Than Doubles Addressable Market in Solera Health's Network via Expanded Hypertension Program, With Dario Now Reaching Greater Than 500,000 Eligible Lives
 DarioHealth Reports First Quarter 2026 Financial and Operating Results
May 13, 2026 DarioHealth Reports First Quarter 2026 Financial and Operating Results
10-Q Quarterly Report for 2026 Q1
May 13, 202610-Q Quarterly Report for 2026 Q1
 DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026
May 04, 2026 DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026
 Dario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative Research
April 20, 2026 Dario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative Research
 Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling
April 13, 2026 Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling
 DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
March 19, 2026 DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
10-K Annual Report for 2025 FY
March 19, 202610-K Annual Report for 2025 FY
 DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026
March 11, 2026 DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026
 Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health
March 10, 2026 Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health
 Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management
March 03, 2026 Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management
 Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms
January 21, 2026 Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms
 Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members
December 10, 2025 Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members
 Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
December 04, 2025 Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
 DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
December 02, 2025 DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
 DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
November 24, 2025 DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
 DarioHealth Reports Third Quarter 2025 Financial and Operating Results
November 13, 2025 DarioHealth Reports Third Quarter 2025 Financial and Operating Results
10-Q Quarterly Report for 2025 Q3
November 13, 202510-Q Quarterly Report for 2025 Q3
 DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform
November 12, 2025 DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform
 DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025
November 06, 2025 DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025
 Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care
October 13, 2025 Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 26, 202512 Health Care Stocks Moving In Friday's Pre-Market Session
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session
September 26, 2025Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket
September 26, 2025Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Thursday's After-Market Session
September 25, 202512 Health Care Stocks Moving In Thursday's After-Market Session
DarioHealth Weighs Big Moves After Surprise Interest From Suitors
September 25, 2025DarioHealth Weighs Big Moves After Surprise Interest From Suitors
10-Q Quarterly Report for 2025 Q2
August 12, 202510-Q Quarterly Report for 2025 Q2
10-Q Quarterly Report for 2025 Q1
May 14, 202510-Q Quarterly Report for 2025 Q1
10-K Annual Report for 2024 FY
March 10, 202510-K Annual Report for 2024 FY
10-Q Quarterly Report for 2024 Q3
November 07, 202410-Q Quarterly Report for 2024 Q3
10-Q Quarterly Report for 2024 Q2
August 08, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
May 15, 202410-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
March 28, 202410-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
November 02, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
August 10, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
May 11, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
March 09, 202310-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
November 14, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
August 15, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
May 12, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
March 22, 202210-K Annual Report for 2021 FY
10-Q Quarterly Report for 2021 Q3
November 15, 202110-Q Quarterly Report for 2021 Q3
10-Q Quarterly Report for 2021 Q2
August 16, 202110-Q Quarterly Report for 2021 Q2

A. Company Overview

DarioHealth Corp is an innovative company that has emerged as a prominent player in the digital health domain, particularly in the management of chronic conditions. It has pioneered the concept of Digital Therapeutics as a Service (DTaaS) to enhance the healthcare experience for individuals with chronic illnesses. The core philosophy of DarioHealth is to disrupt traditional healthcare delivery, which often relies on a provider-centered approach, by implementing user-centric methodologies for continuous and customized care. This vision aims to make healthcare more accessible, affordable, and effective by leveraging technologies and behavioral science to meet users at their individual health journeys.

The company has expanded its offerings through strategic acquisitions to integrate a comprehensive, multi-condition platform. Notably, the acquisition of Twill, a digital-first solution focused on mental and physical well-being, signifies DarioHealth's commitment to providing a holistic approach to health management that encompasses both physical and mental health needs. Currently, the platform covers a wide array of health conditions, including diabetes, hypertension, weight management, musculoskeletal issues, and behavioral health.

Product and Service Offerings

DarioHealth provides an extensive suite of digital health solutions designed to help users manage chronic conditions effectively. Its products are segmented into several categories:

  1. Dario Metabolic Solutions (Dario Evolve): This solution targets metabolic health challenges such as diabetes, pre-diabetes, hypertension, and weight management. It utilizes a combination of software applications, connected devices, and live coaching to guide users towards long-term behavior change and improved health outcomes.
  2. Dario Musculoskeletal Solutions (Dario Move): Dario Move focuses on addressing common musculoskeletal conditions through digital physical therapy programs and posture training that empower users to improve strength and mobility.
  3. Dario Behavioral Health Solutions (Dario Elevate): This component optimizes access to mental health support. It features an AI-driven screener that helps users navigate their mental health needs by connecting them to appropriate resources and evidence-based care.
  4. Dario Full Suite (Dario One): This comprehensive offering consolidates all of DarioHealth's solutions into one integrated platform designed for seamless user experiences and better health outcomes by addressing multiple chronic conditions concurrently.

Integrative Technology Platform

At the heart of DarioHealth’s offerings is its advanced technological infrastructure, featuring an AI-driven user journey engine that personalizes user experiences and treatment pathways. This journey engine adapts to user behavior over time, thereby enhancing engagement and retention. It is built on insights generated from years of user data, which enables customization of the care journey tailored to individual user preferences and health requirements.

The platform also integrates live coaching from certified health professionals—including Certified Diabetes Educators and mental health clinicians—who guide users through their chronic condition management processes, thereby increasing accountability and support.

Clinical Impact and Outcomes

DarioHealth's approach is characterized by a focus on real-world clinical data that supports its effectiveness claims. The company has conducted numerous studies demonstrating significant improvements in clinical outcomes for users engaging with their solutions. Notable metrics include reduced blood glucose levels in diabetes patients, improved medication adherence, and lowered healthcare resource utilization. The integration of physical activity tracking has also shown promising results in managing chronic conditions.

Market Strategy

Since transitioning to a business-to-business-to-consumer (B2B2C) model, DarioHealth has signed over 100 contracts with health plans and employers to deliver its digital therapies. Not only has this strategy broadened the company's market reach, but it has also enriched the data pool that informs its healthcare solutions. The synergistic effects of acquisitions and integrated services lead to improvements in user experience and engagement metrics, generating a compelling value proposition for enterprise clients.

The company is actively expanding its partnerships within the healthcare ecosystem, including collaborations with major health plans and Fortune 100 employers, positioning itself as an integral part of the healthcare delivery system. As digital health technologies evolve, DarioHealth intends to leverage these relationships to enhance its service offerings and drive greater utilization of its digital health solutions.

Acquisitions and Business Development

DarioHealth's growth strategy includes pursuing strategic acquisitions that enhance its product offerings and expand its market reach. Apart from the acquisition of Twill, the company has also integrated assets from Upright Technologies and PsyInnovations, which provide additional expertise in musculoskeletal and behavioral health, respectively. This multi-faceted approach aims to establish DarioHealth as a comprehensive provider capable of addressing overlapping health issues that commonly affect individuals with chronic conditions.

Financial Health and Projections

The company expects significant financial improvements in the wake of its acquisitions and integration efforts, projecting enhanced revenue scales and reduced operational costs. The combination of these synergies is anticipated to lead toward increased profits and sustained long-term growth, with a focus on continually improving the quality of care provided through its digital health solutions.

Government Regulation and Compliance

DarioHealth operates in a heavily regulated industry, with its products classified as medical devices subject to the scrutiny of regulatory bodies like the FDA in the United States. The company has achieved necessary certifications such as ISO 13485 for quality management systems and CE Marks for compliance in European markets. DarioHealth is continually navigating the complex landscape of healthcare regulations to ensure the safety and efficacy of its digital health offerings.

Stock Infos

SectorHealth Care
IndustryHealth Services
CEOErez Raphael

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.